Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATPase, aminophospholipid transporter, class I, type 8A, member 2 pseudogene 3 (ATP8A2P3) is annotated as a human pseudogene, meaning it is a non-functional copy of a protein-coding gene, in this case related to ATP8A2, which encodes an aminophospholipid translocase involved in membrane phospholipid transport[1][2][5]. Pseudogenes do not encode functional proteins but may exert regulatory effects on gene expression through non-coding RNA functions, such as acting as competitive endogenous RNA (ceRNA) or microRNA decoys, though this has not specifically been shown for ATP8A2P3[4]. There is no evidence this pseudogene encodes an active transporter or serves as a drug target, and it is not associated directly with any human disease or clinically relevant function. In summary, ATP8A2P3 is a noncoding pseudogene, not a therapeutic target, and does not possess biological or pharmacological functions attributed to protein-coding members of the ATPase family. There are no known drugs, biomarkers, or safety concerns associated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATPase, aminophospholipid transporter, class I, type 8A, member 2 pseudogene 3 (ATP8A2P3).